Stocks TelegraphStocks Telegraph
Stock Ideas

ATHE Financial Statements and Analysis

NASDAQ : ATHE

Alterity Therapeutics Limited

$4.14
-0.37-8.20%
Open: 9:56 AM
63.29
BESG ScoreESG Rating

ATHE FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

ATHE Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

Date2024-06-302024-03-312023-12-312023-09-302022-12-31
reported currencyAUDUSDAUDUSDUSD
calendar year20242024202420242023
periodQ4Q3Q2Q1Q2
revenue2.119M690.715K1.901M610.929K812.117K
cost of revenue73.612K38.255K73.917K31.167K54.474K
gross profit2.045M652.46K1.827M579.762K757.643K
gross profit ratio0.9650.9450.9610.9490.933
research and development expenses12.283M4.005M6.361M2.045M2.643M
general and administrative expenses2.706M882.367K2.066M664.026K949.129K
selling and marketing expenses-5.005K-1.631K18.382K-1.501K12.687K
selling general and administrative expenses2.745M880.736K2.084M662.525K961.816K
other expenses00000
operating expenses14.984M4.885M8.445M2.707M-3.46M
cost and expenses15.102M4.924M8.519M2.738M-3.406M
interest income150.019K0118.40K03.874K
interest expense00000
depreciation and amortization73.612K5.538K73.917K5.90K6.696K
ebitda-14.615M-4.228M-8.334M-2.123M-2.849M
ebitda ratio-6.899-6.121-4.443-3.474-3.508
operating income-15.102M-4.233M-8.519M-2.127M-2.856M
operating income ratio-7.128-6.128-4.482-3.482-3.516
total other income expenses net412.988K134.648K111.345K35.787K157.076K
income before tax-14.689M-4.098M-8.408M-2.092M-2.699M
income before tax ratio-6.933-5.933-4.424-3.424-3.323
income tax expense-2.072M15.026K-1.901M-1.168K35.366K
net income-12.616M-4.113M-6.507M-2.092M-2.734M
net income ratio-5.955-5.955-3.424-3.424-3.367
eps-0.002-0.001-0.003-0.001-0.001
eps diluted-0.002-0.001-0.003-0.001-0.001
weighted average shs out6.308B4.797B2.503B2.503B2.412B
weighted average shs out dil6.308B4.794B2.503B2.503B2.412B
Graph

ATHE Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

Date2024-06-302024-03-312023-12-312023-09-302023-06-30
reported currencyAUDUSDAUDAUDAUD
calendar year20242024202420242023
periodQ4Q3Q2Q1Q4
cash and cash equivalents12.639M8.241M12.32M7.92M15.774M
short term investments00000
cash and short term investments12.639M8.241M12.32M7.92M15.774M
net receivables4.042M2.621M5.806M3.732M8.666M
inventory01.51M01.002.57M
other current assets2.356M1.551M3.867M2.486M39.764K
total current assets19.037M12.413M21.993M14.138M27.049M
property plant equipment net186.883K121.859K199.483K128.235K268.863K
goodwill00000
intangible assets00000
goodwill and intangible assets00000
long term investments00000
tax assets00000
other non current assets0001.000
total non current assets186.883K121.859K199.483K128.236K268.863K
other assets00000
total assets19.224M12.535M22.193M14.266M27.318M
account payables581.137K378.936K3.631M2.334M1.716M
short term debt107.131K69.855K179.092K115.127K107.177K
tax payables15.994K027.126K027.93K
deferred revenue00000
other current liabilities4.67M3.055M655.227K438.643K2.559M
total current liabilities5.374M3.504M4.493M2.888M4.382M
long term debt51.914K33.851K76.505K49.18K103.207K
deferred revenue non current00000
deferred tax liabilities non current00000
other non current liabilities0001.0019.503K
total non current liabilities51.914K33.851K76.505K49.181K122.71K
other liabilities00000
capital lease obligations159.045K103.706K76.505K164.307K210.384K
total liabilities5.426M3.538M4.569M2.937M4.505M
preferred stock00000
common stock223.153M145.509M214.976M138.195M213.971M
retained earnings-214.161M-139.646M-201.631M-129.616M-195.131M
accumulated other comprehensive income loss03.134M4.278M2.75M0
other total stockholders equity4.806M0003.972M
total stockholders equity13.798M8.997M17.623M11.329M22.813M
total equity13.798M8.997M17.623M11.329M22.813M
total liabilities and stockholders equity19.224M12.535M22.193M14.266M27.318M
minority interest00000
total investments00000
total debt159.045K076.505K49.18K210.384K
net debt-12.48M-8.241M-12.244M-7.871M-15.563M
Graph

ATHE Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

Date2024-06-302024-03-312023-12-312023-09-302023-06-30
reported currencyAUDAUDAUDAUDAUD
calendar year20242024202420242023
periodQ4Q3Q2Q1Q4
deferred income tax00-106.423K1.994M1.187M
stock based compensation00106.423K100.375K107.299K
change in working capital001.622M484.984K-4.271M
accounts receivables002.681M861.873K-1.588M
inventory00000
accounts payables00112.931K0-926.013K
other working capital00-1.173M-376.889K-1.756M
other non cash items4.579M0-51.546K37.657K2.501M
net cash provided by operating activities-8.111M0-4.863M549.00K-6.198M
investments in property plant and equipment278.000-2.00K-4.00K2.566K
acquisitions net00000
purchases of investments00000
sales maturities of investments00000
other investing activites-1.00K01.00K0-29.15K
net cash used for investing activites-722.000-1.00K-4.00K-26.584K
debt repayment-10.37K000-32.154K
common stock issued8.122M8.924M1.126M05.833K
common stock repurchased00000
dividends paid00000
other financing activites-72.02K-673.00K-156.00K-17.00K-13.679K
net cash used provided by financing activities8.166M8.251M970.00K-17.00K-40.00K
effect of forex changes on cash39.356K307.00K-495.00K408.00K94.00K
net change in cash318.459K5.981M-4.389M936.00K-6.171M
cash at end of period12.639M18.301M12.32M16.709M15.773M
cash at beginning of period12.32M12.32M16.709M15.773M21.944M
operating cashflow-8.111M0-4.863M549.00K-6.198M
capital expenditure278.000-2.00K-4.00K2.566K
free cash flow-8.111M0-4.865M545.00K-6.196M
Graph

Frequently Asked Questions

How did Alterity Therapeutics Limited do last quarter? What was its Total Revenue and Cost of Revenue?

A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, ATHE generated $2.12M in revenue last quarter, while its costs came in at $73.61K.

Last quarter, how much Gross Profit did Alterity Therapeutics Limited report?

A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Alterity Therapeutics Limited reported a $2.04M Gross Profit for the quarter ended Jun 30, 2024.

Have ATHE's Total Operating Expenses and Operating Income been favorable recently?

Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. ATHE incurred $14.98M worth of Operating Expenses, while it generated -$15.10M worth of Operating Income.

How much Net Income has ATHE posted recently?

The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Alterity Therapeutics Limited, the company generated -$12.62M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.

At the end of the last quarter, how much Cash and Equivalents did Alterity Therapeutics Limited have?

The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Alterity Therapeutics Limited as of the end of the last quarter was $12.64M.

What are ATHE's Total Net Receivables for the last quarter?

Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, ATHE had Total Net Receivables of $4.04M.

In terms of Total Assets and Current Assets, where did Alterity Therapeutics Limited stand at?

An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of ATHE were $19.04M, while the Total Assets stand at $19.22M.

As of the last quarter, how much Total Debt did Alterity Therapeutics Limited have?

The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of ATHE's debt was $159.05K at the end of the last quarter.

What were ATHE's Total Liabilities during the last reported quarter?

A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, ATHE reported total liabilities of $5.43M.

How much did ATHE's Working Capital change over the last quarter?

Working Capital Change for ATHE was $0.00 over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.

ATHE generated how much cash from operating activities?

An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. ATHE generated -$8.11M of Cash from Operating Activities during its recently reported quarter.

What was ATHE's latest reported Net Change in Cash?

An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. ATHE reported a $318.46K Net Change in Cash in the most recent quarter.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph